Tumor-LN-oC´s first PRESS RELEASE

September 2, 2021

European (EU) H2020 funded Tumor-LN-oC project, officially started on 1st May, 2021, Tumor-LN-oC proposes the development and validation of tumor-lymph node-on-chip platform that will connect primary surgically removed human tumors and lymph node tissue from the same cancer patient. This will allow us to study the interaction of primary tumors with lymph nodes, identify their chemical signature, and offer personalized treatment relying on molecular characterization of lymph node metastasizing cells.

Read the Press Release announcing the launch of the Tumor-LN-oC project.

Photo by Roman Kraft on Unsplash
Other news